Legal Opinion
In re Plavix Marketing, Sales Practices & Products Liability Litigation
United States Judicial Panel on Multidistrict Litigation
Decided February 12, 2013No. MDL No. 2418PublishedCited by 13 opinions
1Opinion of the Court
TRANSFER ORDER
JOHN G. HEYBURN II, Chairman.
Before the Panel: Pursuant to 28 U.S.C- § 1407, common defendants Brisv tol-Myers Squibb Company (Bristol-Myers) and Sanofí-Aventis U.S¡ LLC, Sar nofi-Aventis U.S. Services Inc., and Sanofi-Synthelabo, Inc. (collectively, Sanofi) move for centralization of this litigation in a federal district court in either New Jersey or New York. The litigation encompasses the 21 actions listed on Schedules A and B.1
Defendant McKesson Corporation supports the motion for centralization. Responding plaintiffs, however, uniformly oppose centralization. If the Panel…
2Cases cited3 opinions
- In Re Glaceau Vitaminwater Marketing & Sales Practices LitigationUnited States Judicial Panel on Multidistrict Litigation · 2011
- In Re FedEx Ground Package System, Inc., Employment Practices LitigationUnited States Judicial Panel on Multidistrict Litigation · 2005
- In re Plavix Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2011
3Cited by13 opinions
- In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices & Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2016
- United States ex rel. Dickson v. Bristol-Meyers Squibb Co.District Court, D. New Jersey · 2015
- In re Lipitor (Atorvastatin Calcium) Marketing, Salespractices & Products Liability Litigation (No. II)United States Judicial Panel on Multidistrict Litigation · 2014
- In re Darvocet, Darvon & Propoxyphene Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2013
- In re Proton-Pump Inhibitor Products Liability Litigation (No. II)United States Judicial Panel on Multidistrict Litigation · 2017
8 more not listed; retrieve them via the Exa API.